Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Shares Issued (2020 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Shares Issued for 6 consecutive years, with $5000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 82.76% to $5000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $34000.0 through Dec 2025, down 74.81% year-over-year, with the annual reading at $19000.0 for FY2025, 82.41% down from the prior year.
  • Shares Issued hit $5000.0 in Q4 2025 for Bolt Biotherapeutics, down from $29000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $495000.0 in Q4 2021 to a low of $5000.0 in Q4 2025.
  • Historically, Shares Issued has averaged $189500.0 across 5 years, with a median of $136500.0 in 2021.
  • Biggest five-year swings in Shares Issued: soared 8760.0% in 2021 and later plummeted 82.76% in 2025.
  • Year by year, Shares Issued stood at $495000.0 in 2021, then crashed by 70.91% to $144000.0 in 2022, then decreased by 26.39% to $106000.0 in 2023, then plummeted by 72.64% to $29000.0 in 2024, then tumbled by 82.76% to $5000.0 in 2025.
  • Business Quant data shows Shares Issued for BOLT at $5000.0 in Q4 2025, $29000.0 in Q4 2024, and $106000.0 in Q4 2023.